These studies also showed that uPA and PAI-1 were statistically independent prognostic biomarkers for patients with breast cancer and importantly were prognostic in the subset of patients with lymph node-negative disease [47,52,56,60,61,63,67,68]. The gene discussed is PLAU; the disease is breast cancer.